Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Albin Österroos"'
Autor:
Anderson Daniel Ramos, Ying Yu Liang, Olga Surova, Smaranda Bacanu, Marc-Antoine Gerault, Tamoghna Mandal, Sophia Ceder, Anette Langebäck, Albin Österroos, George A. Ward, Jonas Bergh, Klas G. Wiman, Sören Lehmann, Nayana Prabhu, Sara Lööf, Pär Nordlund
Publikováno v:
Cell Reports, Vol 43, Iss 10, Pp 114784- (2024)
Summary: Cellular phenotypes of apoptosis, as well as the activation of apoptosis caspase cascades, are well described. However, sequences and locations of early biochemical effector events after apoptosis initiation are still only partly understood.
Externí odkaz:
https://doaj.org/article/52b21ee609b64646a145af27d421b87c
Autor:
Nona Struyf, Albin Österroos, Mattias Vesterlund, Cornelia Arnroth, Tojo James, Stephanie Sunandar, Georgios Mermelekas, Anna Bohlin, Kerstin Hamberg Levedahl, Sofia Bengtzén, Rozbeh Jafari, Lukas M. Orre, Janne Lehtiö, Sören Lehmann, Päivi Östling, Olli Kallioniemi, Brinton Seashore-Ludlow, Tom Erkers
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-7 (2024)
Abstract Consistent handling of samples is crucial for achieving reproducible molecular and functional testing results in translational research. Here, we used 229 acute myeloid leukemia (AML) patient samples to assess the impact of sample handling o
Externí odkaz:
https://doaj.org/article/b137e1c0bbc24a2a9826fbbf5bd104d4
Autor:
Quang Thinh Trac, Yudi Pawitan, Tian Mou, Tom Erkers, Päivi Östling, Anna Bohlin, Albin Österroos, Mattias Vesterlund, Rozbeh Jafari, Ioannis Siavelis, Helena Bäckvall, Santeri Kiviluoto, Lukas M. Orre, Mattias Rantalainen, Janne Lehtiö, Sören Lehmann, Olli Kallioniemi, Trung Nghia Vu
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract Despite some encouraging successes, predicting the therapy response of acute myeloid leukemia (AML) patients remains highly challenging due to tumor heterogeneity. Here we aim to develop and validate MDREAM, a robust ensemble-based predictio
Externí odkaz:
https://doaj.org/article/708587f7449c4c56ba44998f3046d58f
Autor:
Gunnar Juliusson, Christer Nilsson, Sören Lehmann, Martin Jädersten, Lovisa Wennström, Linda Fogelstrand, Panagiotis Baliakas, Tatjana Pandzic, Lucia Cavelier, Anna Eriksson, Albin Österroos, Anna Thunström, Benedicte Piauger, Bertil Uggla, Emma Ölander, Gustav Orrsjö, Jörg Cammenga, Kristina Myhr-Eriksson, Petter Willner Hjelm, Stefan Deneberg, Thoas Fioretos, Martin Höglund, Vladimir Lazarevic
Publikováno v:
HemaSphere, Vol 7, p e38749b6 (2023)
Externí odkaz:
https://doaj.org/article/32aa3e03ec294219906a1419015ccc1c
Autor:
Albin Österroos, Tânia Maia, Anna Eriksson, Martin Jädersten, Vladimir Lazarevic, Lovisa Wennström, Petar Antunovic, Jörg Cammenga, Stefan Deneberg, Fryderyk Lorenz, Lars Möllgård, Bertil Uggla, Emma Ölander, Eliana Aguiar, Fernanda Trigo, Martin Höglund, Gunnar Juliusson, Sören Lehmann
Publikováno v:
Haematologica, Vol 107, Iss 7 (2022)
With increasingly effective treatments, early death (ED) has become the predominant reason for therapeutic failure in patients with acute promyelocytic leukemia (APL). To better prevent ED, patients with high-risk of ED must be identified. Our aim wa
Externí odkaz:
https://doaj.org/article/34cdf435ea0a47ee95c6601eadd0be27
Autor:
Anna Eriksson, Marie Engvall, Lucy Mathot, Albin Österroos, Martin Rippin, Lucia Cavelier, Claes Ladenvall, Panagiotis Baliakas
Publikováno v:
Clinical Cancer Research. :OF1-OF9
Purpose: In acute myeloid leukemia (AML), somatic mutations (commonly missense, nonsense, and frameshift indels) in RUNX1 are associated with a dismal clinical outcome. Inherited RUNX1 mutations cause familial platelet disorder. As approximately 5%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a978443cfa860c68e46f96aaaf27c7aa
https://doi.org/10.1158/1078-0432.ccr-23-0122
https://doi.org/10.1158/1078-0432.ccr-23-0122
Autor:
Panagiotis Baliakas, Claes Ladenvall, Lucia Cavelier, Martin Rippin, Albin Österroos, Lucy Mathot, Marie Engvall, Anna Eriksson
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fdedb4854b4fe45256abb01e85f6599
https://doi.org/10.1158/1078-0432.22692627
https://doi.org/10.1158/1078-0432.22692627
Autor:
Panagiotis Baliakas, Claes Ladenvall, Lucia Cavelier, Martin Rippin, Albin Österroos, Lucy Mathot, Marie Engvall, Anna Eriksson
Supplementary Table 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75a0ed03ade9bcefd8f93f5798295f06
https://doi.org/10.1158/1078-0432.22692621
https://doi.org/10.1158/1078-0432.22692621
Autor:
Panagiotis Baliakas, Claes Ladenvall, Lucia Cavelier, Martin Rippin, Albin Österroos, Lucy Mathot, Marie Engvall, Anna Eriksson
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e857eb03033732e19d66a4891ba90b82
https://doi.org/10.1158/1078-0432.22692624
https://doi.org/10.1158/1078-0432.22692624
Autor:
Albin, Österroos, Tânia, Maia, Anna, Eriksson, Martin, Jädersten, Vladimir, Lazarevic, Lovisa, Wennström, Petar, Antunovic, Jörg, Cammenga, Stefan, Deneberg, Fryderyk, Lorenz, Lars, Möllgård, Bertil, Uggla, Emma, Ölander, Eliana, Aguiar, Fernanda, Trigo, Martin, Höglund, Gunnar, Juliusson, Sören, Lehmann
Publikováno v:
Haematologica. 107(7)
With increasingly effective treatments, early death (ED) has become the predominant reason for therapeutic failure in patients with acute promyelocytic leukemia (APL). To better prevent ED, patients with high-risk of ED must be identified. Our aim wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::221a5846197272c5eb9b2aad8a2120c8
https://pubmed.ncbi.nlm.nih.gov/35081691
https://pubmed.ncbi.nlm.nih.gov/35081691